Gum Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 01-07-2024
- Paid Up Capital ₹ 5.97 Cr
as on 01-07-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 2.62%
(FY 2022)
- Profit 21.35%
(FY 2022)
- Ebitda -10.86%
(FY 2022)
- Net Worth 11.68%
(FY 2022)
- Total Assets 9.59%
(FY 2022)
About Gum Pharma
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Madhav Gupta and Sanjiv Kumar serve as directors at the Company.
- CIN/LLPIN
U24232DL2010PTC197641
- Company No.
197641
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gum Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhav Gupta  | Nominee Director | 08-Apr-2010 | Current |
| Sanjiv Kumar | Director | 08-Apr-2010 | Current |
Financial Performance and Corporate Structure Insights of Gum Pharma.
Gum Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.62% increase. The company also saw a substantial improvement in profitability, with a 21.35% increase in profit. The company's net worth Soared by an impressive increase of 11.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gum Pharma?
In 2022, Gum Pharma had a promoter holding of 83.74% and a public holding of 16.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gum Pharma?
Unlock and access historical data on people associated with Gum Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gum Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gum Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
